Minakem Header W48

Minakem Header W48

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

ISD Immunotech

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Post an Enquiry

Digital Content

ISD Immunotech, a Novo Seeds Portfolio Company, Enters Strategic Research Collaboration for the Development of a Novel Lupus Treatment

Details:

ISD and Biogen will work together to develop ISD's lead compound, ISD 017, which is being developed to treat severe lupus - systemic lupus erythematosus (SLE).

Lead Product(s): ISD-017

Therapeutic Area: Immunology Product Name: ISD-017

Highest Development Status: Preclinical Product Type: Peptide

Partner/Sponsor/Collaborator: Biogen

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Collaboration November 23, 2020

ASK
US

Upload
your Pipeline Activity

POST ENQUIRY